Lydian

Lydian converts CO₂ emissions, water, and renewable electricity into carbon-neutral fuels at low cost.

Lydian designs and constructs CO₂-to-fuels plants to produce synthetic aviation fuel. The company aims to enable sustainable flight by leveraging expertise in chemical engineering, power markets, and commercialization, with pilot production underway and plans to scale to commercial volumes by 2028.

The company discusses sustainable aviation fuel (SAF).

The company works to reduce carbon emissions in the aviation industry.

The company aims to decarbonize the aviation industry.

Lydian secures $43 million in funding from Breakthrough Energy Ventures’ new airline-backed SAF fund. The investment supports development of sustainable aviation fuel (SAF) technologies. The round highlights growing industry focus on decarbonizing air travel through alternative fuels.

Aug 2026Chemical & Engineering NewsNews article

Lydian secures $43 million in Series A funding from Breakthrough Energy Ventures to scale production of cost-competitive synthetic aviation fuel. The investment supports commercial-scale deployment of the company’s technology, aiming to address aviation’s reliance on fossil fuels. Lydian’s approach focuses on making synthetic fuels economically viable for widespread adoption in the industry.

Jul 2026PR NewswireNews article

Lydian launches a **25,000-square-foot R&D Center of Excellence** at Hood Park to advance its **low-cost synthetic fuel production technology**. The facility supports the company’s mission to develop scalable, cost-effective synthetic fuels using novel methods. Lydian, based in Massachusetts, aims to accelerate research and development in this emerging energy sector.

Dec 2025PR NewswireNews article

Lydian demonstrates a working pilot for its sustainable aviation fuel technology, producing electric fuels without fossil inputs. The process targets aviation emissions by converting renewable energy into drop-in jet fuel. The company highlights scalability for commercial deployment in upcoming trials.

Jan 2025PR NewswireNews article